A new therapeutic target for proteasome inhibitor resistant multiple myeloma

  • Pitson, Stuart (Primary Chief Investigator (PCI))
  • Spencer, Andrew (Chief Investigator (CI))
  • Wallington-Beddoe, Craig (Chief Investigator (CI))
  • Flynn, Bernard (Associate Investigator (AI))

Project: Research

Project Details

StatusActive
Effective start/end date1/01/1931/12/21

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): AUD676,588.50

Keywords

  • myeloma
  • proteasome
  • endoplasmic reticulum
  • targeted therapy
  • sphingolipids